Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest update is out from EKF Diagnostics Holdings ( (GB:EKF) ).
EKF Diagnostics Holdings plc reported record analyzer sales and improved earnings for the first half of 2025, with gross margins rising to 50.2% and a 16.1% increase in pre-tax profit. The company is on track to meet full-year revenue and adjusted EBITDA growth expectations, supported by strong performances in Hematology and β-HB product lines. The strategic development plan is yielding results, with increased production capacity and a focus on high-margin products driving profitability. The company also completed a share buyback and canceled a loan facility due to strong cash generation, indicating a robust financial position.
The most recent analyst rating on (GB:EKF) stock is a Hold with a £31.00 price target. To see the full list of analyst forecasts on EKF Diagnostics Holdings stock, see the GB:EKF Stock Forecast page.
Spark’s Take on GB:EKF Stock
According to Spark, TipRanks’ AI Analyst, GB:EKF is a Neutral.
EKF Diagnostics Holdings has a solid financial foundation with strong profit margins and low leverage, which are the most significant factors in its score. The technical analysis shows a positive trend, although momentum is not strong. The valuation is moderate, with a P/E ratio suggesting fair pricing, but the lack of a dividend yield is a downside for income investors.
To see Spark’s full report on GB:EKF stock, click here.
More about EKF Diagnostics Holdings
EKF Diagnostics Holdings plc is an AIM-listed global diagnostics business focused on Point-of-Care analyzers, particularly in Hematology and Diabetes, and Life Sciences, offering contract fermentation services for clinically important enzymes and proteins. The company manufactures Beta-Hydroxybutyrate (β-HB) for use in quantitative ketone testing and other clinical applications. Headquartered in Penarth, near Cardiff, EKF operates five manufacturing sites across the US and Germany, selling products in over 120 countries worldwide.
Average Trading Volume: 295,695
Technical Sentiment Signal: Hold
Current Market Cap: £131.6M
For detailed information about EKF stock, go to TipRanks’ Stock Analysis page.